Stocks
Exelixis, Inc.EXEL
NASDAQHealthcareBiotechnology$41.24+0.17%
Focused on oncology drug development, this biotechnology company develops and commercializes targeted cancer therapies, with its lead product cabozantinib marketed as Cabometyx for several forms of advanced kidney and liver cancer. Revenue is largely driven by this franchise alongside collaboration ...
Market Cap: $11.1B52W Range: $32.38 – $49.62
This page tracks all publicly disclosed congressional trades in Exelixis, Inc. (EXEL), a company in the Healthcare sector. 2 members of Congress have disclosed trades in this stock, including 2 purchases and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
3
Unique Politicians
2
Buys
2
Sells
1
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-01-12 | Rohit Khanna | buy | $1K – $15K |
| 2024-01-10 | Rohit Khanna | buy | $1K – $15K |